Advisors Preferred, LLC Mereo Biopharma Group PLC Transaction History
Advisors Preferred, LLC
- $645 Million
- Q3 2024
A detailed history of Advisors Preferred, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Advisors Preferred, LLC holds 18,188 shares of MREO stock, worth $67,113. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,188
Previous 24,813
26.7%
Holding current value
$67,113
Previous $89,000
16.85%
% of portfolio
0.01%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding MREO
# of Institutions
84Shares Held
107MCall Options Held
209KPut Options Held
479K-
Rubric Capital Management LP New York, NY15.3MShares$56.5 Million1.75% of portfolio
-
Janus Henderson Group PLC London, X012.3MShares$45.6 Million0.03% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.72MShares$35.8 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.53MShares$35.2 Million1.33% of portfolio
-
Mangrove Partners New York, NY8.73MShares$32.2 Million4.66% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $461M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...